Clinical Trial Update: Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating neoadjuvant chemotherapy alone or with the PRGN-2009 immunotherapy vaccine for newly diagnosed HPV-associated oropharyngeal cancer; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Hpv-associated Oropharyngeal Cancer
• Oropharyngeal Cancer

Drugs mentioned

• PRGN-2009
• neoadjuvant chemotherapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Squamous Cell Carcinoma of the Head and Neck, Oropharynx | Phase 2 | Status: RECRUITING